FEATURED CONTENT

• Robust Models For Supporting PV And Medical Information Activity

  Learn how outsourcing local pharmacovigilance and medical information activities to an established safety organization can provide high-quality expertise and technology that meets demand.

• Biotech, Pharma Embrace Regulatory Technology Outsourcing

  Managing risks, time, effort, and costs while meeting regulatory demands can be overwhelming. Discover how blending human expertise with technology can increase efficiencies and reduce error.

• Increase Efficiency & Reduce Risk With A Molecule-To-Market Action Plan

  No two journeys to drug approval look the same. That’s why it is critical to design a target product profile and regulatory approach to guide your program from the outset.

• IQVIA Labeling Compliance Solutions

  Learn how by having a strategy for “core-to-carton” compliance, drug developers can avoid risks for patients and their company.

• Strategies To Achieve Labeling Harmonization Amid A Legal Entity Change

  A strong labeling team is vital to ensure successful navigation of the legal entity change process, including developing a timeline, executing data transfers, and mitigating compliance risks.

• Creating Endpoint Adjudication Committees And Management Strategies

  In complying with regulations, trial sponsors may need expert guidance on best practices for developing an EAC and overall strategy and oversight of key endpoint objectives and processes.

• How To Ensure Local-Level Pharmacovigilance Compliance And Efficiency

  Managing local pharmacovigilance and medical information is no easy feat, but a local QPPV, a regulatory intelligence database, and innovative AI technology might be the solutions trials need.

• Being Prepared: Business Continuity Planning In The Life Science Industry

  Business continuity planning (BCP) ahead of the next pandemic or natural disaster is essential to ensure the success of any enterprise, but it's particularly crucial for companies in the life science industry.

• Medical Information Teams Embrace Artificial Intelligence

  Global biopharma companies are constantly looking for ways to increase awareness and engage health care professionals (HCPs) seeking medical information. Explore why many see artificial intelligence (AI) as a big part of the solution.

• Pharmaceutical Medical Information Requests Drive Patient Safety

  When patients couldn't reach their physicians during the pandemic, they turned to pharma companies for information, signaling an evolution in the engagement between consumers and healthcare brands.

• Humans And Artificial Intelligence Unite

  In this white paper, discover how medical information organizations are redefining how people and AI can work together to rapidly respond to the surge in customer requests.

• Humans And AI Join Forces

  Medical information experts Simon Johns and Richard Marcil discuss how artificial intelligence is redefining the way healthcare professionals engage with MI teams.

• Medical Information Goes Digital

  The move to digital-first for medical information offers life sciences companies a way to exceed customer expectations with technology that enables real-time, faster and more satisfying interactions.

• Optimizing Regulatory Lifecycle Management

  If a medicine’s sponsor wants to maximize the impact of a product on patients, providers, and their own bottom line, the need to proactively make regulatory affairs part of the lifecycle planning strategy is critical to the planning process.